Neurology and Men's Health, Part 2: ALS
The second entry in our “Neurology and Men’s Health” series focuses on amyotrophic lateral sclerosis, or ALS.
Faculty Registration now open! Writing from the Reader’s Perspective
Registration now open for SOM Faculty
Registration will open to all others on June 25
CHDI launch event highlights research to "end disease where it begins"
The Children’s Health & Discovery Initiative (CHDI) held a launch event on Thursday, May 31, 2018 at the Chesterfield Building in downtown Durham to highlight research into the p
Treatment Advances Give Hope to People with Brain Metastases
Lisa VanTress didn’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016.
Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.
Researchers Identify Promising New Drug Target for Lethal Prostate Cancer
Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer,
Stages of Complex Grant Development (Part 2)
In the last post, I identified five stages for successful complex grant development.